Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Cerus's peak revenue was $201.3M in 2024. The peak quarterly revenue was $56.8M in 2024(q4).
Cerus's revenue increased from $2.4m in 1999 to $201.3M currently. That's a 8,260.51% change in annual revenue.
| Fiscal year / year | Cerus revenue |
|---|---|
| 2009 | $18.0M |
| 2010 | $23.1M |
| 2011 | $33.0M |
| 2012 | $36.8M |
| 2013 | $39.7M |
| 2014 | $36.4M |
| 2015 | $34.2M |
| 2016 | $39.3M |
| 2017 | $51.3M |
| 2018 | $76.1M |
| 2019 | $93.8M |
| 2020 | $114.2M |
| 2021 | $159.5M |
| 2022 | $188.3M |
| 2023 | $186.8M |
| 2024 | $201.3M |
How accurately did Cerus' revenue projections match actual performance?
Cerus saw the greatest revenue growth in 2001, when revenue increased by 145.0%.
Cerus had the lowest revenue growth in 2007, when revenue changed by -60.97%.
| Year | Cerus growth |
|---|---|
| 2009 | 9%↑ |
| 2010 | 29%↑ |
| 2011 | 43%↑ |
| 2012 | 11%↑ |
| 2013 | 8%↑ |
| 2014 | -8%↓ |
| 2015 | -6%↓ |
| 2016 | 15%↑ |
| 2017 | 31%↑ |
| 2018 | 48%↑ |
| 2019 | 23%↑ |
| 2020 | 22%↑ |
| 2021 | 40%↑ |
| 2022 | 18%↑ |
| 2023 | -1%↓ |
| 2024 | 8%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $3.5M | $4.2M | $4.8M | $5.5M |
| 2010 | $5.7M | $5.9M | $5.0M | $5.0M |
| 2011 | $6.6M | $6.8M | $9.2M | $8.0M |
| 2012 | $8.8M | $9.2M | $8.3M | $10.5M |
| 2013 | $9.7M | $10.2M | $10.5M | $9.2M |
| 2014 | $7.9M | $8.6M | $10.4M | $9.6M |
| 2015 | $7.7M | $8.8M | $8.0M | $9.7M |
| 2016 | $7.6M | $9.3M | $10.4M | $10.1M |
| 2017 | $7.0M | $9.5M | $10.8M | $16.3M |
| 2018 | $13.5M | $15.4M | $15.4M | $16.5M |
| 2019 | $17.5M | $18.2M | $18.1M | $20.9M |
| 2020 | $18.6M | $21.5M | $23.6M | $28.2M |
| 2021 | $23.4M | $31.4M | $36.1M | $39.9M |
| 2022 | $37.4M | $40.9M | $39.7M | $44.1M |
| 2023 | $31.0M | $38.8M | $39.7M | $46.7M |
| 2024 | $38.3M | $45.2M | $45.9M | $56.8M |
Do you work at Cerus?
Did Cerus meet its revenue projections?
| CEO | William ‘Obi’ M. Greenman |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 254 |
| Date Founded | 1991 |
| Headquarters | Concord, California |
| Number of Locations | 1 |
| Revenue | $201.3M |
| Net Income | -$42,779,000 |
| Gross Proft | $120.6M (2024) |
| EBITDA | ($57.6M) (2015) |
| PE Ratio | -15.00 |
| Tax Rate | -0.0% |
| Market Capitalization | $313.8M |
| Total Assets | $218,092,000 |
| Ticker | CERS |
Cerus received early financing of $30.0M on 2014-07-01.
| Series | Round size | Date |
|---|---|---|
| Grant - Cerus | $15M | 05/2018 |
| Post-IPO Debt - Cerus | $30M | 07/2014 |
| Investors | Security type |
|---|---|
| Oxford Finance LLC | Post-IPO Debt - Cerus |
Cerus's top competitor, Haemonetics, earned an annual revenue of $1.3B.
Cerus's smallest competitor is Cell Vault with revenue of $71.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Haemonetics | $64,516 | $1.3B | 3,300 | 166 |
| Taiga Biotech | $45,529 | $1.2M | 15 | - |
| Hemostemix | $45,003 | $284.9K | 8 | - |
| BioTime | $50,309 | $3.4M | 101 | - |
| Cell Vault | $44,823 | $71,000 | 1 | - |
| Signature Science | $70,814 | $42.0M | 350 | 20 |
| Invitro | $51,481 | $710,000 | 25 | - |
| Alder Biopharmaceuticals | $94,428 | $6.5M | 202 | - |
| Digene Corporation | $67,724 | $29.0M | 200 | - |
| ABC Laboratories | $72,507 | $72.0M | 3,000 | 5 |
Zippia gives an in-depth look into the details of Cerus, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cerus. The employee data is based on information from people who have self-reported their past or current employments at Cerus. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cerus. The data presented on this page does not represent the view of Cerus and its employees or that of Zippia.
Cerus may also be known as or be related to Cerus, Cerus Corp. and Cerus Corporation.